2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a has been researched along with Carcinoma, Basal Cell, Pigmented in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Intes, X; Ozturk, MS; Rohrbach, D; Sunar, U | 1 |
| Bellnier, DA; Dougherty, TJ; Greco, WR; Loewen, GM; Nava, H; Oseroff, AR; Pandey, RK; Tsuchida, T | 1 |
1 review(s) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Mesoscopic fluorescence tomography of a photosensitizer (HPPH) 3D biodistribution in skin cancer.
Topics: Administration, Topical; Animals; Carcinoma, Basal Cell; Chlorophyll; Dermoscopy; Imaging, Three-Dimensional; Mice; Mice, Transgenic; Microscopy, Fluorescence; Photosensitizing Agents; Reproducibility of Results; Sensitivity and Specificity; Skin Absorption; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution; Tomography, Optical | 2014 |
1 other study(ies) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Blood Proteins; Carcinoma, Basal Cell; Chlorophyll; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Esophageal Neoplasms; Humans; Lung Neoplasms; Middle Aged; Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms | 2003 |